Siloam International Hospitals (IDX:SILO) - Share price, News & Analysis

SILO fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	3/6

SILO Stock Overview

PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia.

Rewards

Trading at 0.1% below our estimate of its fair value

Earnings are forecast to grow 17.15% per year

Earnings grew by 158.1% over the past year

Risk Analysis

Unstable dividend track record

Siloam International Hospitals Competitors

Mitra Keluarga Karyasehat

IDX:MIKA

Rp37.9t

Medikaloka Hermina

IDX:HEAL

Rp20.1t

Sarana Meditama Metropolitan

IDX:SAME

Rp6.7t

Sejahteraraya Anugrahjaya

IDX:SRAJ

Rp2.2t

Price History & Performance

Summary of all time highs, changes and price drops for Siloam International Hospitals
Historical stock prices
Current Share Price	Rp1,050.00
52 Week High	Rp1,412.50
52 Week Low	Rp896.88
Beta	0.023
1 Month Change	-12.50%
3 Month Change	5.99%
1 Year Change	0.90%
3 Year Change	95.35%
5 Year Change	-22.58%
Change since IPO	-12.95%

Shareholder Returns

	SILO	ID Healthcare	ID Market
7D	5.0%	3.4%	-1.0%
1Y	0.9%	16.8%	18.2%

Return vs Industry: SILO underperformed the ID Healthcare industry which returned 14.4% over the past year.

Return vs Market: SILO underperformed the ID Market which returned 15.6% over the past year.

Price Volatility

Is SILO's price volatile compared to industry and market?
SILO volatility
SILO Average Weekly Movement	6.7%
Healthcare Industry Average Movement	5.5%
Market Average Movement	6.3%
10% most volatile stocks in ID Market	12.2%
10% least volatile stocks in ID Market	3.0%

Stable Share Price: SILO is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: SILO's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1996	13,251	Darjoto Setyawan	https://www.siloamhospitals.com

PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services.

Siloam International Hospitals Fundamentals Summary

How do Siloam International Hospitals's earnings and revenue compare to its market cap?
SILO fundamental statistics
Market Cap	Rp13.60t
Earnings (TTM)	Rp629.51b
Revenue (TTM)	Rp9.30t

21.6x

P/E Ratio

1.5x

P/S Ratio

Is SILO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
SILO income statement (TTM)
Revenue	Rp9.30t
Cost of Revenue	Rp5.82t
Gross Profit	Rp3.48t
Other Expenses	Rp2.85t
Earnings	Rp629.51b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	48.62
Gross Margin	37.42%
Net Profit Margin	6.77%
Debt/Equity Ratio	0.4%

How did SILO perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

36%

Payout Ratio

Valuation

Is Siloam International Hospitals undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

0.1%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: SILO (IDR1050) is trading below our estimate of fair value (IDR1051.42)

Significantly Below Fair Value: SILO is trading below fair value, but not by a significant amount.

Price To Earnings Ratio

PE vs Industry: SILO is poor value based on its PE Ratio (21.6x) compared to the ID Healthcare industry average (20.2x).

PE vs Market: SILO is poor value based on its PE Ratio (21.6x) compared to the ID market (18.8x).

Price to Earnings Growth Ratio

PEG Ratio: SILO is poor value based on its PEG Ratio (1.3x)

Price to Book Ratio

PB vs Industry: SILO is overvalued based on its PB Ratio (2.1x) compared to the ID Healthcare industry average (1.9x).

Future Growth

How is Siloam International Hospitals forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

17.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SILO's forecast earnings growth (17.2% per year) is above the savings rate (7%).

Earnings vs Market: SILO's earnings (17.2% per year) are forecast to grow faster than the ID market (11% per year).

High Growth Earnings: SILO's earnings are forecast to grow, but not significantly.

Revenue vs Market: SILO's revenue (9.1% per year) is forecast to grow slower than the ID market (10.5% per year).

High Growth Revenue: SILO's revenue (9.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SILO's Return on Equity is forecast to be low in 3 years time (10.4%).

Past Performance

How has Siloam International Hospitals performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

35.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SILO has high quality earnings.

Growing Profit Margin: SILO's current net profit margins (6.8%) are higher than last year (3.1%).

Past Earnings Growth Analysis

Earnings Trend: SILO's earnings have grown significantly by 35.6% per year over the past 5 years.

Accelerating Growth: SILO's earnings growth over the past year (158.1%) exceeds its 5-year average (35.6% per year).

Earnings vs Industry: SILO earnings growth over the past year (158.1%) exceeded the Healthcare industry 121.6%.

Return on Equity

High ROE: SILO's Return on Equity (9.8%) is considered low.

Financial Health

How is Siloam International Hospitals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: SILO's short term assets (IDR3,486.1B) exceed its short term liabilities (IDR2,337.1B).

Long Term Liabilities: SILO's short term assets (IDR3,486.1B) exceed its long term liabilities (IDR523.2B).

Debt to Equity History and Analysis

Debt Level: SILO has more cash than its total debt.

Reducing Debt: SILO's debt to equity ratio has reduced from 0.5% to 0.4% over the past 5 years.

Debt Coverage: SILO's debt is well covered by operating cash flow (5650.7%).

Interest Coverage: SILO's interest payments on its debt are well covered by EBIT (22.9x coverage).

Balance Sheet

Dividend

What is Siloam International Hospitals's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

1.65%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: SILO's dividend (1.65%) is higher than the bottom 25% of dividend payers in the ID market (1.12%).

High Dividend: SILO's dividend (1.65%) is low compared to the top 25% of dividend payers in the ID market (4.17%).

Stability and Growth of Payments

Stable Dividend: Too early to tell whether SILO's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if SILO's dividend payments are increasing as they only just started paying a dividend.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (35.7%), SILO's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (23.4%), SILO's dividend payments are well covered by cash flows.

Next Steps

Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

5.0yrs

Average management tenure

CEO

Darjoto Setyawan (63 yo)

1.08yrs

Tenure

Mr. Darjoto Setyawan, B.Sc serves as President Director of PT Siloam International Hospitals Tbk since April 28, 2021. Mr. Setyawan has been the Managing Director of Mining and Resources at Rajawali Group...

Leadership Team

Experienced Management: SILO's management team is seasoned and experienced (5 years average tenure).

Board Members

Experienced Board: SILO's board of directors are considered experienced (3.9 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/18 00:00
End of Day Share Price	2022/05/18 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31